Resistant Starch Constipation Randomized Trial: What the Evidence Says

Quick Answer

Resistant Starch Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• At the taxonomic level, pregnancy is typically associated with an expansion of the phyla Pseudomonadota (formerly Proteobacteria) and Actinomycetota (formerly Actinobacteria), alongside an increase in the relative abundance of specific genera such as. [Cai Linyan (2026); evidence level 3]
• Specific dietary components are associated with the abundance of certain bacterial taxa; intake of total fat and unsaturated fatty acids correlates withand, while protein intake is linked toand. [Cai Linyan (2026); evidence level 3]
• This condition significantly impacts patients' quality of life, causing discomfort, abdominal pain, and reduced productivity, while also imposing substantial healthcare costs due to frequent medical consultations and ongoing treatment. [Li Rong (2025); evidence level 4]
• Fiber supplementation, though beneficial for some, can lead to bloating and discomfort, while stimulant laxatives may result in dependency without addressing the underlying causes. [Li Rong (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For resistant starch constipation randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Cai Linyan (2026). Gestational constipation and the gut microbiota: mechanisms, interventions, and implications for maternal and offspring health. DOI: 10.3389/fnut.2026.1819825. PMCID: PMC13194093. PMID: 42180565. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13194093/
• Li Rong (2025). Ruminococcus bromii alleviates constipation by pullulanase-driven resistant starch degradation and microbiota modulation. DOI: 10.1038/s41522-025-00877-6. PMCID: PMC12789625. PMID: 41390334. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12789625/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.